A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
Conditions
Interventions
- BIOLOGICAL: PG4 Multivalent Vaccine
- BIOLOGICAL: PG4 Multivalent Vaccine
- BIOLOGICAL: PG4 Multivalent Vaccine
- BIOLOGICAL: 20 Valent Pneumococcal Conjugate Vaccine (20vPnC)
Sponsor
Pfizer